SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-21-035802
Filing Date
2021-07-06
Accepted
2021-07-06 17:15:43
Documents
5
Effectiveness Date
2021-07-06
Reference 429
333-231477

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea143728-s8_relmadatherap.htm S-8 244694
2 OPINION OF SICHENZIA ROSS FERENCE LLP ea143728ex5-1_relmada.htm EX-5.1 8213
3 CONSENT OF MARCUM LLP ea143728ex23-1_relmada.htm EX-23.1 2755
4 GRAPHIC ex5-1_001.jpg GRAPHIC 10528
5 GRAPHIC img_001.jpg GRAPHIC 5718
  Complete submission text file 0001213900-21-035802.txt   279468
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-257723 | Film No.: 211075096
SIC: 2834 Pharmaceutical Preparations